Royal Bank Gets Approval for Share-Buyback Program
By Robb M. Stewart
Royal Bank of Canada has gotten the green light to buy back up to 2.1% of its shares over a one-year period and plans to redeem subordinated debentures and preferred shares.
The bank, Canada's largest by market value, said Monday the Toronto Stock Exchange and Office of the Superintendent of Financial Institutions approved a normal course issuer bid to buy for cancellation up to 30 million of its shares.
The planned buybacks, which Royal Bank in late May said it planned to seek the approval for, can take place from Wednesday through June 11, 2025.
As well, the Toronto-based bank said it plans to redeem all of its issued and outstanding non-viability contingent capital non-cumulative five-year rate reset first preferred shares, series BB, on Aug. 24 for cash at a price of 25 Canadian dollars (US$18.16) a share. Royal Bank, which has 20 million series BB shares outstanding representing C$500 million of capital, said the redemptions will be financed out of the general corporate funds.
Royal Bank said it also intends to redeem all outstanding non-viability contingent capital 2.74% subordinated debentures due July 25, 2029, for the full principal amount plus accrued interest. The redemption will occur on July 25, and the current principal amount of the subordinated debentures outstanding is C$1.5 billion.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
June 10, 2024 09:08 ET (13:08 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks